Dixit et al. found that the m6A-related gene YTHDF2 is aberrantly expressed in glioblastoma compared to normal neural stem cells and could be a therapeutic target for the treatment of MYC signaling in glioblastoma39. This evidence concerns the gene MYC and glioblastoma.